ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,081 | +55.6% | 121,792 | +143.9% | 0.00% | 0.0% |
| Q2 2023 | $248,187 | -11.5% | 49,937 | -12.0% | 0.00% | 0.0% |
| Q1 2023 | $280,469 | -77.7% | 56,775 | -71.7% | 0.00% | -80.0% |
| Q4 2022 | $1,260,290 | -52.6% | 200,364 | -18.7% | 0.01% | -61.5% |
| Q3 2022 | $2,660,000 | +8.4% | 246,322 | -8.5% | 0.01% | +30.0% |
| Q1 2022 | $2,454,000 | +515.0% | 269,320 | +1605.4% | 0.01% | +233.3% |
| Q4 2020 | $399,000 | +79.7% | 15,792 | +167.7% | 0.00% | 0.0% |
| Q3 2020 | $222,000 | -84.3% | 5,900 | -89.2% | 0.00% | -62.5% |
| Q4 2019 | $1,418,000 | +508.6% | 54,596 | +538.8% | 0.01% | +300.0% |
| Q3 2019 | $233,000 | -16.5% | 8,547 | -17.8% | 0.00% | -33.3% |
| Q2 2019 | $279,000 | -25.8% | 10,401 | -20.0% | 0.00% | -25.0% |
| Q1 2019 | $376,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |